ScreenCell® logo
Devis Rapide

The Prognostic Value of the Circulating Tumor Cell-Based Four mRNA Scoring System: A New Non-Invasive Setting for the Management of Bladder Cancer

  • Cancer de la vessie
  • Par : Consuelo Amantini, Federica Maggi, Jacopo Adolfo Rossi de Vermandois, Marilena Gubbiotti, Antonella Giannantoni, Ettore Mearini, Massimo Nabissi, Daniele Tomassoni, Giorgio Santoni, Maria Beatrice Morelli

DOI : 

PMID :

  • 35804889
Télécharger l'article

Abstract

Non disponibles.

Mots clés

  • TRPM4; bladder cancer; circulating tumor cells; mRNA scoring system; recurrence.

Partager sur

Navigation

Quel kit correspond à mon application ?

Les derniers articles.

Optimum diagnostic pathway and pathologic confirmation rate of early stage lung cancer: Results from the VIOLET randomised controlled trial

  • Rosie A Harris, Elizabeth A Stokes, Tim J P Batchelor, Eveline Internullo, Doug West, Simon Jordan, Andrew G Nicholson, Ian Paul, Charlotte Jacobs, Michael Shackcloth, Sarah Feeney, Vladimir Anikin, Niall McGonigle, Richard Steyn, Maninder Kalkat, Dionisios Stavroulias, May Havinden Williams, Syed Qadri, Karen Dobbs, Vipin Zamvar, Lucy Macdonald, Surinder Kaur, Chris A Rogers, Eric Lim; VIOLET trialists
  • DOI : 10.1016/j.lungcan.2024.108070

Rapid separation of mononuclear hodgkin from multinuclear reed-sternberg cells

  • Narisorn Kongruttanachok, Yvon E Cayre, Hans Knecht, Sabine Mai
  • DOI : 10.1532/LH96.12023

An assessment of diagnostic performance of a filter-based antibody-independent peripheral blood circulating tumour cell capture paired with cytomorphologic criteria for the diagnosis of cancer

  • Maxim B Freidin, Andee Tay, Dasha V Freydina, Dimple Chudasama, Andrew G Nicholson, Alexandra Rice, Vladimir Anikin, Eric Lim
  • DOI : 10.1016/j.lungcan.2014.05.017
Pour l'amélioration de la
prise en charge des patients
grâce à l'analyse des CTC
Demander un devis
Demander la brochure